Bloodwork question about AOD-9604. Baseline, five years in, and the numbers moved in a direction I did not expect.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took five years to be sure.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Animal data is much of what exists here and the human stuff is thin and small.
Anyone got a paper worth reading on this rather than a write-up of a paper?
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
What is the first thing you would read if you were starting from zero?
Is a baseline blood test really necessary before starting something like this? Not on AOD-9604 but the pattern is familiar.
Narrow conclusion.